• 1
    Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277 301.
  • 2
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187192.
  • 3
    Lanham JC, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg–Strauss syndrome. Medicine (Baltimore) 1984;63:6581.
  • 4
    Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg–Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:2637.
  • 5
    Eustace JA, Nadasdy T, Choi M. The Churg–Strauss syndrome. J Am Soc Nephrol 1990;10:10281055.
  • 6
    Noth I, Strek ME, Leff AR. Churg–Strauss syndrome. Lancet 2003;361:587594.
  • 7
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al. The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:10941100.
  • 8
    Guillevin L, Pagnoux C, Mouthon L. Churg–Strauss syndrome. Semin Respir Crit Care Med. 2004;25:535545.
  • 9
    Jennet JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:15121523.
  • 10
    Savage CO, Harper R, Adu D. Primary systemic vasculitis. Lancet 1997;349:553558.
  • 11
    Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss Syndrome. Arthritis Rheum 2005;52:29262936.
  • 12
    Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D et al. Antineutrophil cytoplasmic antibodies and the Churg–Strauss syndrome. Ann Intern Med 2005;143:632638.
  • 13
    Chumbley LC, Harrison EG, De Remee RA. Allergic granulomatosis and angiitis (Churg–Strauss syndrome). Mayo Clin Proc 1977;52:477484.
  • 14
    Hayakawa H, Sato A, Yagy T, Shimizu T, Miyajima H, Taniguchi M et al. Clinical features and prognosis of Churg–Strauss syndrome. Nihon Kyobu Shikkan Gakkai Zasshi. 1993;31:5964.
  • 15
    Global Strategy for Asthma Management and Prevention. Revised 2002. NIH Publication No 02-3659. National institutes of Health, National Heart, Lung, and Blood Institute.
  • 16
    Good allergy practice. Standards of care for providers and purchasers of allergy services within the National Health Service. Royal College of Physicians and Royal College of Pathologists. Clin Exp Allergy 1995;25:586595.
  • 17
    Lemanske RF Jr. A review of the current guidelines for allergic rhinitis and asthma. J Allergy Clin Immunol 1998;101:S392S396.
  • 18
    Van Cauwemberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116134.
  • 19
    Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl Med 1989;320:271277.
  • 20
    Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991;325:10671071.
  • 21
    Pearce N, Pekkanene J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999;54:268272.
  • 22
    Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995;172:265267.
  • 23
    Asero R, Bottazzi G. Clinical features of patients showing Candida hypersensitivity: an observational study. J Investig Allergol Clin Immunol 2004;14:309311.
  • 24
    Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA. The relative risk of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989;19:419424.
  • 25
    Asthma in women after menopause. Hormone replacement therapy may explain why many women over 50 develop this disease. Health News 2005;11:45.
  • 26
    Platts-Mills TA. Role of allergens in asthma and airway hyperresponsiveness: relevance to immunotherapy and allergen avoidance. In: KalinerMA, PersonCG, editors. Asthma: Its Pathology and Treatment. New York: Marcel Dekker, 1991, Chapter 22.
  • 27
    Nelson HS. The importance of allergens in the development of asthma and the persistence of symptoms. J Allergy Clin Immunol 2000;105:S628S632.
  • 28
    Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcoch AJ. Importance of dust mite and alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993;23:812820.
  • 29
    Déchamp C, Méon H. Ambroisies, Polluants Biologiques. Lyon: Arpam-édition, 2002, 68.
  • 30
    Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahan-Schmid B. The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol 2005;138:337346.
  • 31
    Yunginger JW, Ahlstedt S, Egglestone PA, Homburger HA, Nelson HS, Ownby DR et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol 2000;105:10771084.
  • 32
    Umibe T, Kita Y, Nakao A, Nakajima H, Fukuda T, Yoshida S et al. Clonal expansion of T cells infiltrating in the airways of no-atopic asthmatic. Clin Exp Immunol 2000;119:390397.